15 Small-Cap Healthcare Stocks Hedge Funds Are Buying
The U.S. healthcare sector has performed better in 2025 compared to the broader market. After two years of weak performance, the healthcare sector kicked off on a strong note in 2025.
Biomarin Pharmaceutical Inc (BMRN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 10,800,059 | $763,456,171 | +3% | 2.43% |
| 2. | Elliott Management Paul Singer | 3,500,338 | $247,438,893 | 1.63% | |
| 3. | AQR Capital Management Cliff Asness | 2,925,805 | $203,987,099 | +128% | 0.21% |
| 4. | Citadel Investment Group Ken Griffin | 1,595,058 | $112,754,650 | +312% | 0.02% |
| 5. | Squarepoint Ops LLC Maxime Fortin (Cio) | 1,388,728 | $98,169,182 | +101% | 0.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $86.75 | 3,625 | Director | 10,905 | 2022-10-31 | Filing | |
| $78.84 | 900 | Director | 30,740 | 2020-08-31 | Filing | |
| $78.22 | 11,900 | Director | 29,840 | 2020-08-31 | Filing | |
| $21.76 | 161 | Officer | 100,574 | 2012-10-31 | Filing | |
| $21.76 | 548 | Officer | 15,294 | 2012-10-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $64.92 | 273 | Officer | 32,700 | 2025-05-02 | Filing | |
| $71.52 | 1,295 | Officer | 16,955 | 2025-03-19 | Filing | |
| $71.28 | 7,034 | Officer | 87,655 | 2025-03-06 | Filing | |
| $68.38 | 1,344 | Officer | 13,105 | 2025-02-24 | Filing | |
| $66.37 | 5,278 | Officer | 68,909 | 2024-11-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,778,999 | $1,680,937,387 | 0.04% | |
| 2. | 19,003,212 | $1,343,337,056 | 0.02% | |
| 3. | 17,773,281 | $1,256,393,234 | 1.04% | |
| 4. | 14,955,240 | $1,057,185,916 | 0.6% | |
| 5. | 9,150,655 | $646,859,812 | 0.14% |
News See All
Billionaire Paul Singer's 10 Stock Picks with Huge Upside Potential
Paul Singer founded Elliott Investment Management in 1977 in New York. It is one of the oldest hedge funds under continuous management and is also one of the largest activist funds in the world.
10 Stocks That Will Make You Rich In 3 Years
The stock market has been facing volatility since the tariffs were announced. This has created fears of a recession, leading many investors to think that this might be the end of the bull market.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2025 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the BioMarin Pharmaceuticals First Quarter 2025 Conference Call. Just a reminder that this conference is being recorded.
Billionaire Andreas Halvorsen's 10 Stock Picks With Huge Upside Potential
Ole Andreas Halvorsen is one of the prominent names among former employees of Julian Robertson's Tiger Management.
20 Takeover Rumors Hedge Funds Are Buying
Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market.
7 Most Profitable Biotech Stocks To Buy Right Now
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
11 Best Gene Therapy Stocks to Buy According to Analysts
Gene therapy is a medical approach that entails changing or modifying genes to treat or prevent disease.
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Paul Singer’s Latest Portfolio: Top 10 Stock Picks
Stock markets are as risky as they have ever been. That’s the sentiment echoed by billionaire investor Paul Singer.
Billionaire Hedge Funds
